
WAVE Life Sciences (NASDAQ:WVE) brought in sales totaling $1.76 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 458.35%, resulting in a loss of $34.78 million. WAVE Life Sciences collected $36.42 million in revenue during Q3, but reported earnings showed a $6.23 million loss.